SCHEMBL8613484

SCHEMBL8613484

CCCCC(=O)Nc1ccc2c(C(=O)NC(N)=Nc3ccccc3)ccnc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
NPC1 O15118 3/20 0.43
ALDH1A1 P00352 6/20 0.41
LMNA P02545 1/20 0.40
HPGD P15428 3/20 0.39
USP2 O75604 1/20 0.39
TSHR P16473 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KDM4E B2RXH2 2/20 0.39
HSD17B10 Q99714 2/20 0.39
GLA P06280 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
PKM P14618 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8619427 0.88 MCHR1 (0.42) RAB9ASMN1; SMN2NPC1ALDH1A1LMNA
SCHEMBL8612684 0.86 CSF1R (0.42) RAB9ASMN1; SMN2NPC1ALDH1A1LMNA
SCHEMBL8619419 0.83 SMO (0.38) RAB9ASMN1; SMN2NPC1ALDH1A1LMNA
SCHEMBL8617741 0.79 SCN2A (0.44) RAB9ASMN1; SMN2NPC1ALDH1A1LMNA
SCHEMBL8614015 0.79 ADRA2A (0.45) RAB9ASMN1; SMN2NPC1ALDH1A1LMNA
SCHEMBL8613223 0.79 SMN1; SMN2 (0.45) RAB9ASMN1; SMN2NPC1ALDH1A1LMNA
SCHEMBL8614313 0.78 RAB9A (0.39) RAB9ASMN1; SMN2NPC1ALDH1A1LMNA
SCHEMBL8620942 0.78 HDAC6 (0.42) ALDH1A1LMNAHPGDTSHRNPSR1
SCHEMBL8615213 0.78 RAB9A (0.42) RAB9ASMN1; SMN2NPC1ALDH1A1LMNA
SCHEMBL8615943 0.78 RAB9A (0.45) RAB9ASMN1; SMN2NPC1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed